A hospital-based study: Risk factors in development of motor complications in 555 Parkinson's patients on levodopa therapy
Tarih
2006Yazar
Ozekmekci, Sibel
Erginoz, Ethem
Delil, Sakir
Apaydin, Hulya
Benbir, Gulcin
Üst veri
Tüm öğe kaydını gösterÖzet
Objectives: Although levodopa (LD) is the gold standard therapy for symptomatic treatment of Parkinson's disease (PD), the chronic use of LD leads to the development of motor complications in almost all patients.
Koleksiyonlar
- Makale [92796]